Impact Biomedical Issues Correction On Merger Exchange Ratio As Reverse Stock Split Takes Effect

Impact Biomedical issued a correction to its prior merger announcement, clarifying that shareholders will receive one Zoar Limited share for each Impact share held immediately before the merger’s effective time after accounting for the reverse stock split. The update clarifies transaction mechanics rather than announcing a change in merger terms or financial outlook.